EirGen Pharma Overview
- Founded
-
2005

- Status
-
Acquired/Merged
- Employees
-
200

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
EirGen Pharma General Information
Description
Developer and manufacturer of high potency, high barrier to entry solid dose products for the pharmaceutical market. The company is fully licensed to manufacture oncology, cytotoxic, steroidal and immunosuppressant molecules in a purpose built high containment facility.
Contact Information
Website
www.eirgen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Primary Office
- Westside Business Park
- Old Kilmeaden Road
- Waterford
- Ireland
+353 (051) 000 000
EirGen Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
EirGen Pharma Patents
EirGen Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3181945-A1 | Hard capsule dosage form and uses thereof | Pending | 31-May-2020 | 0000000000 | |
AU-2021285494-A1 | Hard capsule dosage form and uses thereof | Pending | 31-May-2020 | 0000000000 | |
CA-3176559-A1 | 25-hydroxyvitamin d for the treatment of sars-cov-2 infection | Pending | 06-Apr-2020 | 0000000000 | |
US-20210308151-A1 | Activating endogenous antimicrobials to treat sars-cov-2 infection | Pending | 06-Apr-2020 | 0000000000 | |
EP-4096660-A1 | Tetrahydrocyclopenta[b]indole compounds for the treatment of renal disease | Pending | 27-Jan-2020 | A61K31/404 |
EirGen Pharma Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Tom Brennan | Chief Technology Officer & Co-Founder | ||
Damien Burke | Head, Operations |
EirGen Pharma Signals
EirGen Pharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|